4/A: Daphne Jones Adjusts AMN Healthcare Holdings

Sentiment:

Statement of Changes in Beneficial Ownership


Daphne E. Jones, a Director at AMN Healthcare Services, Inc., has filed an amended Form 4 to correct previous ownership reporting and to reflect new equity awards.

Summary

  • Daphne E. Jones, a Director at AMN Healthcare Services, Inc. (AMN), has filed an amended Form 4 to correct an administrative error in a previous filing.
  • The amendment corrects the total number of AMN Common Stock beneficially owned following a reported transaction from 17,124 shares to 16,124 shares.
  • The filing also reports the acquisition of 8,325 shares of AMN Common Stock upon the vesting of Restricted Stock Units (RSUs) granted on May 2, 2025.
  • Additionally, 8,304 new RSUs were granted on May 1, 2026, under the AMN Healthcare 2025 Equity Plan, which vest on the earlier of the one-year anniversary of the grant date or the 2027 Annual Meeting of Shareholders.
  • These new RSUs will settle on the date of the director's separation from service, as per the reporting owner's irrevocable election.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reflecting routine administrative corrections and standard equity award transactions for a director.

Positives

  • Correction of an administrative error in previous SEC filings, ensuring accurate reporting of beneficial ownership.
  • Vesting of 8,325 Restricted Stock Units (RSUs), indicating continued equity participation and alignment with company performance.
  • Grant of 8,304 new RSUs, demonstrating ongoing incentive for future performance and retention.

Negatives

  • An administrative error in a prior filing led to an overstatement of beneficial ownership by 1,000 shares.

Risks

  • The filing does not explicitly mention any new risks. However, the nature of RSU grants and vesting is subject to the company's continued performance and stock price, which inherently carries market risk.

Future Outlook

The filing indicates that 8,304 RSUs granted on May 1, 2026, will vest on the earlier of the one-year anniversary of the grant date or the date of the Company's Annual Meeting of Shareholders in 2027. These RSUs will settle on the director's separation from service.

Industry Context

StockSavvy.ai notes that insider transactions, particularly the acquisition of equity through vesting and grants, are common within the healthcare staffing industry as a means of executive compensation and aligning management interests with shareholder value. The correction of an administrative error is also a routine occurrence in SEC filings.

Stakeholder Impact

  • Shareholders: The correction of the filing ensures transparency and accuracy in reporting beneficial ownership, which is crucial for investor confidence. The vesting and grant of RSUs align director incentives with long-term shareholder value.

Next Steps

  • The 8,304 RSUs granted on May 1, 2026, are scheduled to vest on the earlier of the one-year anniversary of the grant date or the 2027 Annual Meeting of Shareholders.
  • Settlement of these RSUs will occur upon the director's separation from service with the Company.

Key Dates

DateDescription
05/01/2026Earliest transaction date reported in the filing; grant date for new RSUs.
05/02/2025Grant date for RSUs that vested on 05/01/2026.
05/04/2026Date of original Form 4 filing that is being amended.
07/09/2026Date of signature for the amended Form 4 filing.

Keywords

AMN Healthcare Services, Form 4, Daphne E. Jones, Beneficial Ownership, Restricted Stock Units, RSUs, Equity Awards, Insider Trading, SEC Filing, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.